Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

TNFRSF8, anti-Human, Clone: rKi-1/779, Abnova™

Catalog No. 89035192 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-035-192 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-035-192 Supplier Abnova Corporation Supplier No. RAB00313
Add to Cart
Add to Cart

Monoclonal Antibody

Specifications

Antigen TNFRSF8
Applications Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone rKi-1/779
Conjugate Unconjugated
Dilution Flow Cytometry (0.5-1 ug/million cells) Immunofluorescence (1-2 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (0.5-1 ug/mL) The optimal working dilution should be determined by the end user.
Formulation In 10 mM PBS (0.05% BSA and 0.05% azide).
Gene tumor necrosis factor receptor superfamily, member 8
Gene Alias CD30/D1S166E/KI-1
Gene Symbols TNFRSF8
Immunogen Original antibody is raised against recombinant protein corresponding to full length human TNFRSF8.
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 943
Test Specificity Recognizes a single chain glycoprotein of 105/120kDa, identified as TNFRSF8.
Target Species Human
Content And Storage Store at 4°C.
Product Type Antibody
Form Liquid
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.